Tocqueville Asset Management’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $4.41K | Sell |
|
|||||
|
2024
Q3 | $7.26K | Sell |
|
|||||
|
2024
Q2 | $56K | Sell |
|
|||||
|
2024
Q1 | $136K | Sell |
|
|||||
|
2023
Q4 | $148K | Buy |
|
|||||
|
2023
Q3 | $100K | Hold |
|
|||||
|
2023
Q2 | $264K | Buy |
|
|||||
|
2023
Q1 | $690K | Sell |
|
|||||
|
2022
Q4 | $846K | Buy |
|
|||||
|
2022
Q3 | $339K | Sell |
|
|||||
|
2022
Q2 | $415K | Buy |
|
|||||
|
2022
Q1 | $391K | Buy |
|
|||||
|
2021
Q4 | $354K | Sell |
|
|||||
|
2021
Q3 | $552K | Sell |
|
|||||
|
2021
Q2 | $572K | Buy |
|
|||||
|
2021
Q1 | $628K | Buy |
|
|||||
|
2020
Q4 | $236K | Buy |
|
|||||
|
2020
Q3 | $204K | Buy |
|